(Q36620554)

15 August 2017

Concurrent conventionally factionated radiotherapy and weekly docetaxel in the treatment of stage IIIb non-small-cell lung carcinoma (English)

1 reference

non-small-cell lung carcinoma

15 August 2017

1 reference

1 reference

1 reference

M I Koukourakis

1

1 reference

15 August 2017

N Bahlitzanakis

2

1 reference

15 August 2017

M Froudarakis

3

1 reference

15 August 2017

A Giatromanolaki

4

1 reference

15 August 2017

V Georgoulias

5

1 reference

15 August 2017

S Koumiotaki

6

1 reference

15 August 2017

M Christodoulou

7

1 reference

15 August 2017

G Kyrias

8

1 reference

15 August 2017

J Skarlatos

9

1 reference

15 August 2017

J Kostantelos

10

1 reference

15 August 2017

K Beroukas

11

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 August 1999

1 reference

British Journal of Cancer

15 August 2017

1 reference

15 August 2017

80

1 reference

15 August 2017

11

1 reference

15 August 2017

1792-1796

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6690599

15 August 2017

0 references

cites work

Phase I study of docetaxel with concomitant thoracic radiation therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363119

Phase II trial of docetaxel in patients with platinum-refractory advanced ovarian cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363119

Docetaxel (Taxotere) is active in non-small-cell lung cancer: a phase II trial of the EORTC Early Clinical Trials Group (ECTG)

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363119

Phase I study of docetaxel administered as a 1-hour intravenous infusion on a weekly basis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363119

Relationships between the structure of taxol analogs and their antimitotic activity

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363119

Thoracic radiation therapy alone compared with combined chemoradiotherapy for locally unresectable non-small cell lung cancer. A randomized, phase III trial.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363119

Studies With RP 56976 (Taxotere): A Semisynthetic Analogue of Taxol

28 June 2018

1 reference

12 December 2020

Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer

1 reference

12 December 2020

Signiicant Effect of Adjuvant Chemotherapy on Survival in Locally Advanced Non-Small-Cell Lung Carcinoma

1 reference

12 December 2020

Phase II study of docetaxel for recurrent or metastatic non-small-cell lung cancer

1 reference

12 December 2020

Radiotherapy alone for non-small cell lung carcinoma. Five-year disease-free survival and patterns of failure

1 reference

12 December 2020

The impact of overall treatment time on the results of radiotherapy for nonsmall cell lung carcinoma

1 reference

12 December 2020

Taxol induces bcl-2 phosphorylation and death of prostate cancer cells

1 reference

12 December 2020

Comparison of induction chemotherapy before radiotherapy with radiotherapy only in patients with locally advanced squamous cell carcinoma of the lung. The Swedish Lung Cancer Study Group

1 reference

12 December 2020

Weekly docetaxel and concomitant boost radiotherapy for non-small cell lung cancer. A phase I/II dose escalation trial

1 reference

12 December 2020

1 reference

12 December 2020

Inoperable non-small cell lung cancer: radiation with or without chemotherapy

1 reference

12 December 2020

A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690599

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/SJ.BJC.6690599

1 reference

15 August 2017

1 reference

15 August 2017

1 reference